Publicaciones en las que colabora con MARÍA DEL ROCÍO HERRERO VANRELL (36)

2024

  1. Chronic Glaucoma Induced in Rats by a Single Injection of Fibronectin-Loaded PLGA Microspheres: IOP-Dependent and IOP-Independent Neurodegeneration

    International Journal of Molecular Sciences, Vol. 25, Núm. 1

  2. Influence of sex on chronic steroid-induced glaucoma: 24-Weeks follow-up study in rats

    Experimental Eye Research, Vol. 238

  3. Topical Insulin Eye Drops: Stability and Safety of Two Compounded Formulations for Treating Persistent Corneal Epithelial Defects

    Pharmaceutics, Vol. 16, Núm. 5

2023

  1. A novel osmoprotective liposomal formulation from synthetic phospholipids to reduce in vitro hyperosmolar stress in dry eye treatments

    Journal of Liposome Research, Vol. 33, Núm. 2, pp. 117-128

  2. Desarrollo de una formulación antiglaucomatosa tópica a partir de una lágrima artificial

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

  3. Long-acting hybrid microemulsion for the simultaneous treatment of glaucoma and ocular surface diseases

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

  4. Microesferas biodegradables cargadas con dexametasona para el desarrollo de modelos animales de glaucoma crónico: la influencia de la adición de fibronectina por doble emulsión

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

  5. New trends towards glaucoma treatment: Topical osmoprotective microemulsions loaded with latanoprost

    Ocular Surface, Vol. 29, pp. 314-330

2022

  1. Artificial Tears: Biological Role of Their Ingredients in the Management of Dry Eye Disease

    International Journal of Molecular Sciences, Vol. 23, Núm. 5

  2. Comparison of the efficacy of topical insulin with autologous serum eye drops in persistent epithelial defects of the cornea

    Acta Ophthalmologica, Vol. 100, Núm. 4, pp. e912-e919

  3. Development of an osmoprotective microemulsion as a therapeutic platform for ocular surface protection

    International Journal of Pharmaceutics, Vol. 623

  4. Mimicking chronic glaucoma over 6 months with a single intracameral injection of dexamethasone/fibronectin-loaded PLGA microspheres

    Drug Delivery, Vol. 29, Núm. 1, pp. 2357-2374

  5. Novel Osmoprotective DOPC-DMPC Liposomes Loaded with Antihypertensive Drugs as Potential Strategy for Glaucoma Treatment

    Pharmaceutics, Vol. 14, Núm. 7

2021

  1. Analysis of parainflammation in chronic glaucoma using vitreous-oct imaging

    Biomedicines, Vol. 9, Núm. 12

  2. Chronic glaucoma using biodegradable microspheres to induce intraocular pressure elevation. Six-month follow-up

    Biomedicines, Vol. 9, Núm. 6

  3. Combined hyperosmolarity and inflammatory conditions in stressed human corneal epithelial cells and macrophages to evaluate osmoprotective agents as potential DED treatments

    Experimental Eye Research, Vol. 211

  4. Influence of sex on neuroretinal degeneration: Six-month follow-up in rats with chronic glaucoma

    Investigative Ophthalmology and Visual Science, Vol. 62, Núm. 13

  5. Long-term corticosteroid-induced chronic glaucoma model produced by intracameral injection of dexamethasone-loaded PLGA microspheres

    Drug Delivery, Vol. 28, Núm. 1, pp. 2427-2446

  6. Modelo animal de glaucoma crónico inducido con microesferas biodegradables: influencia de la adición de dexametasona

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 60-62

  7. Novel use of plga microspheres to create an animal model of glaucoma with progressive neuroretinal degeneration

    Pharmaceutics, Vol. 13, Núm. 2, pp. 1-20